ACG 2021 Annual Scientific Meeting

Symposium 1A: ACG Past Presidents’ Symposium

Moderator: Sunanda V. Kane, MD, MSPH, FACG

• Intestinal Dysbiosis and Recurrent C. difficile: Impact and Clinical Solutions
  Past President: Christina M. Surawicz, MD, MACG
  Jessica R. Allegretti, MD, MPH
  Discuss and apply emerging therapeutic options for dysbiosis and recurrent C. difficile.
• New Technologies in GERD and How to Use Them in the Clinical Setting
  Past President: Joel E. Richter, MD, MACG
  Marcelo F. Vela, MD, MSCR, FACG
  Recognize evolving technologies in GERD and how to use them in the clinical setting.
• Improving Access, Acceptability, Quality, and Cost-Effectiveness of Colon Cancer Screening
  Past President: Mark B. Pochapin, MD, FACG
  John M. Inadomi, MD, FACG
  Appraise and apply contemporary best evidence in the management of colon cancer screening.

Symposium 1B: Complications of Advanced Liver Disease
Moderator: Norah A. Terrault, MD, MPH, FACG

• Updates in Current Management of Ascites, SBP, and HRS
  Jasmohan S. Bajaj, MD, MSc, FACG
  Discuss best practices in the evaluation of abdominal ascites, spontaneous bacterial peritonitis, and acute kidney injury in patients with liver cirrhosis, and apply current evidence-based guideline recommendations.
• Update in Liver Transplantation: Implications for the GI Provider
  Norah A. Terrault, MD, MPH, FACG
  Summarize new UNOS policies governing organ allocation for liver transplantation, and outline evidence-based recommendations for the general gastroenterologist caring for patients both pre- and post-transplantation.
• Current Concepts in the Management of Hepatic Encephalopathy
  R. Todd Frederick, MD
  Review current and evolving guidelines for the diagnosis and management of occult and overt hepatic encephalopathy.

Symposium 1C: Update on Endoscopic Resection of Colorectal Lesions
Moderator: Tonya R. Kaltenbach, MD, MS, FACG

• Optical Diagnosis of Benign and Malignant Colorectal Lesions
  Sarah K. McGill, MD
  Identify the signature features of benign and malignant colorectal lesions and apply classifications to enhance real-time histologic prediction of lesions.
• Cold Snare Polypectomy for Complete Removal of Small Colorectal Lesions
  Swati G. Patel, MD
  Discuss the updated USMSTF recommendations on optimal polypectomy techniques for small colorectal lesions.
• EMR of Large Colorectal Lesions
  Tonya R. Kaltenbach, MD, MS, FACG
  Describe the techniques for endoscopic mucosal resection of large colon polyps, and identify best practices including when to refer to a specialist.
• Prevention and Management of Large Polyp Resection Complications
  Douglas K. Rex, MD, MACG
  Identify methods to prevent and manage complications of large polyp resection.
• Quality and Competency in Colorectal Lesion Removal: Training and Sustaining
  Roy M. Soetikno, MD, FACG
  Summarize competency learning curves and optimal training strategies for colorectal lesion removal, including simulation-based learning.

Hidden in Plain Sight: Bringing Women Into the Scope of Gastroenterology
Presenter: Amy S. Oxentenko, MD, FACG
Introduced by: Brian E. Lacy, MD, PhD, FACG, and Brennan M. Spiegel, MD, MSHS, FACG
Detail the impact of women in the course of history of medicine and gastroenterology.

Symposium 2A: Starting, Switching, and Stopping Therapy in IBD
Moderator: Christina Y. Ha, MD, FACG

• Starting Therapy in IBD
  Bincy P. Abraham, MD, FACG
  Summarize treatment strategies for initiating therapy in mild and moderate-severe Crohn’s disease and ulcerative colitis.
• Switching Therapy in IBD
  Raymond K. Cross, MD, MS, FACG
  Decide when to switch within and out of medication class in IBD, including loss of response, immunogenicity, adverse events, and biosimilars.
• Stopping and De-Escalating Therapy in IBD
  Christina Y. Ha, MD, FACG
  Describe a practical approach to de-escalation and monitoring of IBD therapy.

Symposium 2B: ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Moderator: Brian E. Lacy, MD, PhD, FACG

• IBS — Making the Diagnosis
  Brian E. Lacy, MD, PhD, FACG
  Discuss the ACG guideline recommendations for diagnostic testing in irritable bowel syndrome.
• Pharmacotherapy of IBS
  Darren M. Brenner, MD, FACG
  Describe the rationale for ACG guideline recommendations for pharmacologic therapy for irritable bowel syndrome.
• Non-Pharmacologic Treatment Options for IBS
  Baharak Moshiree, MD, MSc
  Interpret the latest ACG guidelines as they relate to the non-pharmacologic management of IBS patients.

Symposium 2C: Live From Las Vegas! The 9th Annual Endoscopy Video Forum

Moderators: Seth A. Gross, MD, FACG, and Vivek Kaul, MD, FACG
Judges: David J. Hass, MD, FACG; Laith H. Jamil, MD, FACG; Pichamol Jirapinyo, MD, MPH; Shivangi T. Kothari, MD, FACG; Saowanee Ngamruengphong, MD; Kevin E. Woods, MD, MPH
Demonstrate interesting endoscopic findings and techniques encountered in daily clinical practice.